Clinical Trial Update: Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib

View source ↗

Summary

Completed Bayer-sponsored clinical trial investigating therapeutic decisions in hepatocellular carcinoma and the use of sorafenib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Carcinoma, Hepatocellular | Status: COMPLETED